BlossomHill Therapeutics files for Nasdaq IPO under ticker BLSM
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- US stock futures steady as oil jumps to two-week high ahead of key earnings
- Oil prices rise as attacks on Saudi Arabia overshadow Trump's Russian supply announcements
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- Iren shares jump 5% in premarket trade on report of Anthropic AI cloud deal
Tweet
Share
E-mailGet Alerts BLSM Hot Sheet
Join SI Premium – FREE
BlossomHill Therapeutics, Inc. has filed for an initial public offering of shares of common stock, according to a statement from the company.
The company has applied to list its common stock on the Nasdaq Global Select Market under the ticker symbol BLSM. The offering is contingent upon receiving approval for the listing. Prior to this offering, there has been no public market for the company's common stock.
The number of shares to be offered and the expected price range per share were not disclosed in the filing. Underwriters for the offering include J.P. Morgan, Leerink Partners, Guggenheim Securities, LifeSci Capital, and H.C. Wainwright & Co.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Broadcom CEO says many AI investors are gamblers
- Dauch Corporation names new CFO in executive leadership shuffle
- Stryker invests $400M in CMR Surgical with option to acquire
Create E-mail Alert Related Categories
Corporate News, Hot Corp. News, IPOsRelated Entities
JPMorgan, IPO, Maynard Um, H.C. Wainwright, Guggenheim, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
